logo

Latest Financial Updates

Read latest financial news update from our blog

The GBP is the strongest and the JPY is the weakest as the NA session begins
The GBP is the strongest and the JPY is the weakest as the NA session begins

The strongest to the weakest of the major currencies The GBP is the strongest and the JPY...

Admin | Finance | 2 months ago

Israeli spyware co NSO moving to bigger offices
Israeli spyware co NSO moving to bigger offices

Israeli cyberattack company NSO Group is leaving its offices in the Apple building in Herz...

Admin | Finance | 2 months ago

Energy & Utilities Roundup: Market Talk
Energy & Utilities Roundup: Market Talk

Photo: LIZ HAMPTON/REUTERS The latest Market Talks covering Energy and Utilities. Publish...

Admin | Finance | 2 months ago

Disney strikes deal with ValueAct as it seeks to stave off billionaire Nelson Peltz
Disney strikes deal with ValueAct as it seeks to stave off billionaire Nelson Peltz

The Walt Disney Company and activist investor ValueAct Capital Management L.P. said Wednes...

Admin | Finance | 2 months ago

16-year-old storms to final of world darts championship with £500,000 prize at stake
16-year-old storms to final of world darts championship with £500,000 prize at stake

Luke Littler made it to the final of the 2023/24 Paddy Power World Darts Championship at A...

Admin | Finance | 2 months ago

Cathedra Bitcoin Provides Operations Update
Cathedra Bitcoin Provides Operations Update

This advertisement has not loaded yet, but your article continues below. Cathedra Bitcoin...

Admin | Finance | 2 months ago

Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

This advertisement has not loaded yet, but your article continues below. Arch Biopartners...

Admin | Finance | 2 months ago

Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats
Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats

This advertisement has not loaded yet, but your article continues below. Optimi Health Gr...

Admin | Finance | 2 months ago

Join Our Newsletter

join our newsletter to receive update from us